Adell Harriman & Carpenter Inc. Acquires 80 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Adell Harriman & Carpenter Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 680 shares of the medical equipment provider’s stock after purchasing an additional 80 shares during the period. Adell Harriman & Carpenter Inc.’s holdings in Intuitive Surgical were worth $334,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of ISRG. Ullmann Wealth Partners Group LLC boosted its stake in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares during the period. Daymark Wealth Partners LLC increased its holdings in shares of Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after purchasing an additional 24 shares during the period. Indiana Trust & Investment Management CO boosted its stake in Intuitive Surgical by 5.3% during the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC grew its position in Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after buying an additional 25 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now directly owns 821 shares of the company’s stock, valued at $402,519.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 53,038 shares of company stock valued at $25,857,344. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $516.31 on Wednesday. The company has a 50-day simple moving average of $489.22 and a two-hundred day simple moving average of $444.82. The firm has a market capitalization of $183.90 billion, a PE ratio of 83.01, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on ISRG shares. BTIG Research set a $535.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.